Ravi Salgia
4Patents
0h-index
15Co-inventors
28Inventor score
Filing activity: May 25, 2018 → Apr 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11390922B2 | C-CBL mutations and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11117894B2 | Pyridopyrazine compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11213510B2 | Thioindirubins | Chemistry; Metallurgy | 0 | Active |
| US11672812B2 | Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.